• English
    • svenska
  • English 
    • English
    • svenska
  • Login
View Item 
  •   Home
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Medicine / Institutionen för medicin
  • Doctoral Theses / Doktorsavhandlingar Institutionen för medicin
  • View Item
  •   Home
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Medicine / Institutionen för medicin
  • Doctoral Theses / Doktorsavhandlingar Institutionen för medicin
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Hutchison-Gilford Progeria Syndrome – A new treatment strategy and the role of prelamin A in oncogenesis

Abstract
Prelamin A, a CaaX-protein is a key structural protein of the inner nuclear lamina, a meshwork lining the inner nuclear envelope. Farnesylated prelamin A is cleaved just upstream of the farnesylcysteine residue to produce mature lamin A. We generated Zmpste24 knockout mice and documented a striking accumulation of farnesylated and methylated prelamin A in cells. Zmpste24 knockout cells exhibit premature senescence and misshapen cell nuclei. Zmpste24 knockout mice show slow growth, hair loss, micrognathia, bone fractures, muscle weakness, and premature death. These phenotypes are similar to those in HGPS. HGPS is caused by a LMNA point mutation that leads to the deletion of 50 amino acids in the carboxyl terminus of prelamin A (eliminating the ZMPSTE24 cleavage site and preventing formation of mature lamin A). Consequently, a mutant farnesylated and methylated prelamin A accumulates at the nuclear rim in HGPS cells, interfering with the nuclear lamina and causing misshapen cell nuclei. Specific Aim and Results of Paper 1: To define the importance of ICMT in the pathogenesis and treatment of progeria. In this project we bred Zmpste24 knockout mice with mice harboring a hypomorphic (reduced expression) allele of Icmt. We found that these mice where protected from most aspects of progeroid disease. They had an increased survival, lack of osteoporosis, and increased strength. Icmt inhibition in cells derived from Zmpste24 KO mice and cells from human progeria patients also showed increased proliferative and somatrophic activity, without affecting the frequency of nuclear shape abnormalities which is one of the hallmark phenotypes of progeria. Specific Aim and Results of Paper 2: To test the hypothesis that prelamin A is a tumor suppressor. We bred Zmpste24 knockout mice with mice expressing a Cre-inducible endogenous oncogenic K-RAS and B-Raf alleles (K-RASLSL/+ and B-RafCA). Groups of mice where then allowed to inhale a Cre- adenovirus to activate the expression of oncogenic K-RASG12D/+ and B-RafV600E in lung cells (these mice normally develop lung adenomas to adenocarcinoma without metastases). 10 and 8 weeks post inhalation mice were euthanized and lungs where prepared for routine histology. Surprisingly, Zmpste24-deficiency had no impact on the development K-RASG12D/+ and B-RafV600E driven tumor except for a reduction in grade. Furthermore, fibroblasts derived from the same mice could be readily transformed and proliferated at the same rate as Zmpste24 competent cells. Finally, K-RASG12D/+, B-RafV600E Zmpste24-fibroblasts had significantly reduced basement membrane invasiveness.
Parts of work
I. Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria. Ibrahim MX, Sayin VI, Akula MK, Liu M, Fong LG, Young SG, Bergo MO. Science. 2013 Jun 14;340(6138):1330-3. doi: 10.1126/science.1238880. Epub 2013 May 16. ::PMID::23686339
 
II. Prelamin A inhibits K-RAS and B-Raf induced invasion but is dispensable for tumorgenesis. Manuscript. Ibrahim MX, Sayin VI, Bergo MO.
 
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Medicine. Department of Molecular and Clinical Medicine
Disputation
Torsdagen den 15 maj 2014, kl.9.00, Hörsal Ivan Östholm, Medicinaregatan 13(LNC)
Date of defence
2014-05-15
E-mail
mohamed.ibrahim@gu.se
URI
http://hdl.handle.net/2077/35196
Collections
  • Doctoral Theses / Doktorsavhandlingar Institutionen för medicin
  • Doctoral Theses from Sahlgrenska Academy
  • Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
View/Open
Cover (4.663Mb)
Thesis frame (9.213Mb)
Abstract (204.3Kb)
Date
2014-04-25
Author
Ibrahim, Mohamed
Keywords
progeria
cancer
Publication type
Doctoral thesis
ISBN
978-91-628-9043-8
978-91-628-9014-8
Language
eng
Metadata
Show full item record

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV